Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC010514 | Panoply™ Human NOTCH1 Knockdown Stable Cell Line | Inquiry |
| CSC-SC010514 | Panoply™ Human NOTCH1 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT0701 | Human NOTCH1 Knockout Cell Line-HeLa | Inquiry |
| CLOE-2550 | Mouse Notch1 Insect Cell Lysate | Inquiry |
| CLOE-2553 | Mouse Notch1 CHO Cell Lysate | Inquiry |
| CLKO-0206 | NOTCH1 KO Cell Lysate-HeLa | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD00108Z | Human NOTCH 1 adenoviral particles | Inquiry |
| LV00401Z | Human NOTCH1 lentiviral particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH353820 | shRNA set against Mouse NOTCH1 (NM_008714.3) | Inquiry |
| SHR008426 | shRNA set against Rat Notch1(NM_001105721.1) | Inquiry |
| SHH218005 | shRNA set against Human NOTCH1(NM_017617.3) | Inquiry |
| SHW001162 | shRNA set against Chicken NOTCH1 (NM_001030295) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFR005312 | Rat Notch1 cDNA Clone(NM_001105721.1) | Inquiry |
| MiUTR1H-06853 | NOTCH1 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-07748 | NOTCH1 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-04237 | NOTCH1 miRNA 3'UTR clone | Inquiry |
| SKO0104 | NOTCH1 Validated sgRNA vector | Inquiry |
| CDCB162637 | Chicken NOTCH1 ORF Clone (NM_001030295) | Inquiry |
| CDCL185502 | Mouse NOTCH1 ORF clone(NM_008714.3) | Inquiry |
| CDCL185503 | Human Notch-1 ORF clone(NM_017617.3) | Inquiry |
| CDCR371903 | Rat Notch1 ORF Clone(NM_001105721.1) | Inquiry |
| CDCS419019 | Human MGC24125 ORF Clone (BC020886) | Inquiry |
Notch-1 is a member of the Notch gene family. The Notch-1 signaling pathway plays an important role in cell proliferation, differentiation, survival, and apoptosis. Its abnormal expression is closely related to the occurrence and development of tumors. In vitro and animal experiments have confirmed that activated Notch-1 can transform normal cells into malignant cells and has abnormal expression in many solid tumors and hematological tumors in humans. Notch-1 is a type I transmembrane protein family that has dual functions of cell surface receptors and nuclear transcriptional regulation. Notch-1 signal transduction occurs mainly between cells, and its ligand is also a transmembrane molecule. The Notch-1 receptor forms a heterodimer through a disulfide bond between the cysteine-rich LIN repeat and the transmembrane region. This dimer is paired with a basic amino acid protease-like protein in the Golgi apparatus. Furine cleaves into the active Notch-1 protein receptor, which can be activated by Jagged-1 ligand.
Figure 1. NOTCH1 protein structure and signaling activation. (Emanuela, R. , et al. 2018)
Notch-1 Signaling Pathway
Abnormal Notch-1 signals are closely related to the occurrence of some tumors. Disturbances in Notch-1 signals can not only directly cause tumors, but also can ultimately induce tumors directly or indirectly through interaction with other signaling pathways. Current research indicates that the Notch-1 signal may be an important meeting point for multiple pathways. Intracellular Notch-1 dysfunction can prevent cell differentiation and eventually induce undifferentiated cells to transform into malignant cells. In some tumors, it can induce cell cycle arrest, inhibit growth and induce apoptosis, and also induce epithelial-mesenchymal transition to maintain tumor cell phenotype.
The study found that the positive expression rate of Notch-1 in ovarian cancer was significantly higher than that of ovarian cystadenomas and normal ovarian epithelial tissues, and it increased with the increase of pathological grade. Notch-1 Receptor As a member of the Notch receptor family that is often concerned, it plays an important role in regulating the growth, proliferation and apoptosis of tumor cells. Notch-1 receptor and its ligand Jagged-1 expression are often used in the diagnosis and prognosis of cancer. Studies have found that patients with negative Notch-1 expression in tumor tissue are prone to relapse and metastasis. A negative Notch-1 expression may be one of the risk factors for early recurrence and metastasis of esophageal squamous cell carcinoma. Patients with this risk factor suggest that early postoperative adjuvant chemotherapy is needed. The expression level of Jagged-1 can be used as an independent prognostic factor for judging the prognosis of renal clear cell carcinoma, and high expression of Jagged-1 indicates a poor prognosis of renal cancer.
Notch-1 and Tumor Treatment
Notch-1 serves as a molecular target for treating tumors. Studies have shown that 50% of patients with T-cell acute lymphoblastic leukemia have an active Notch-1 gene mutation, suggesting that it may be an ideal target for molecular therapy. Bioinformatics software predicts that miR-34a and 3'UTR of Notch-1 are highly homologous. Overexpression of miR-34a can reduce the expression of target gene Notch-1 and inhibit the proliferation of bladder tumor cells. It was found that SiRNA targeting the Notch-1 gene can inhibit tumor growth and promote apoptosis in nude mice. The mechanism may be closely related to changes in bal-2 and bax expression. Nanotechnology was used to construct the vector and increase the expression of miR-144 to down-regulate the target gene Notch-1, thereby inhibiting the growth of colon cancer cells. Studies have shown that Notch-1 inhibits colon cancer cell growth by interacting with the Akt / NF-κB / mTOR signaling pathway.
References: